NCT02553928View on ClinicalTrials.gov

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Alzheimer Dementia (AD)
Interventions
DRUG

Memantine (once daily)

DRUG

Memantine (twice daily)

Trial Locations (6)

Unknown

CN001, Beijing

CN006, Fujian

CN004, Shandong

CN002, Tianjin

CN007, Xi'an

CN003, Zhejiang

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02553928 - Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer | Biotech Hunter | Biotech Hunter